ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hepatitis C"

  • 2020 American Transplant Congress

    Comparable Outcomes for Simultaneous Liver-Kidney Transplantation with HCV NAT-Positive Donors

    M. L. Samoylova1, B. I. Shaw1, S. J. Kesseli1, L. McElroy1, Y. Patel2, S. Sanoff2, A. S. Barbas1

    1Surgery, Duke University Hospital, Durham, NC, 2Medicine, Duke University Hospital, Durham, NC

    *Purpose: To evaluate the impact of hepatitis C virus (HCV) Nucleic Acid Amplification-positive (NAT+) donors on outcomes following simultaneous liver-kidney (SLK) transplantation.*Methods: We used the…
  • 2020 American Transplant Congress

    Anticipated Cost Savings of Using Lungs from Hepatitis C-Positive Lung Donors for Hepatitis C-Negative Recipients

    K. Ryland1, J. Mallea2, J. Moriarty3, L. White4, B. Borah5, J. Naessens3

    1Transplantation, Mayo Clinic, Jacksonville, FL, 2Medicine, Mayo Clinic, Jacksonville, FL, 3Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, 4Health Sciences Research, Mayo Clinic, Jacksonville, FL, 5Health Sciences Research, Mayo Clinic, Rochester, MN

    *Purpose: We assessed the cost savings generated by additional organ availability due to utilizing lungs from hepatitis-C infected donors for transplantation in comparison to existing…
  • 2020 American Transplant Congress

    Preemptive Direct Acting Antiviral Therapy as Prophylaxis in Donor HCV-Positive to Recipient HCV-Negative Solid Organ Transplant: a Comprehensive Review

    M. Mavuram, S. Mavuram, H. Samant, S. Pandit, B. Samant, J. Morris, J. Alexander

    Gastroenterology, Louisiana State University of Health Sciences Shreveport, Shreveport, LA

    *Purpose: With the advent of highly effective and safe oral Direct acting Antiviral agents (DAAs), several transplant centers have adopted protocols for using HCV positive…
  • 2020 American Transplant Congress

    Lowering Meld, Diminishing Length of Stay, and Increasing Liver Transplant Numbers Comes Through the Generosity of Others: Declined HCV-NAT Offers Subsequently Transplanted Have Excellent Outcomes

    R. Gilroy, S. Sell, J. Krong, A. Gagnon, I. Zendejas, S. Fujita, M. Rodriguez, D. Alonso

    Transplant Services, Intermountain Healthcare, Murray, UT

    *Purpose: There is variability between programs in the acceptance of organ offers. This paper examines offer, acceptance and program performance with HCV NAT positive donor…
  • 2020 American Transplant Congress

    Financial Analysis of Donor HCV+ Kidney in HCV- Recipients

    D. Axelrod1, K. Lentine2, R. Balakrishnan1, T. Alhamad3, S. Chang3, H. Xiao2, B. Kasiske4, M. Schnitzler2, R. Bloom5

    1University of Iowa, Iowa City, IA, 2Saint Louis Univ, Saint Louis, MO, 3Washington Univ, Seattle, WA, 4SRTR, Minneapolis, MN, 5Univ of Pennsylvania, Philadelphia, PA

    *Purpose: Use of organs from viremic hepatitis C positive donors (dHCV+) in recipients without HCV has been demonstrated to improve access to kidney transplant (KTx).…
  • 2020 American Transplant Congress

    A Follow-Up Over Time to the Impact of Reactive Anti-HCV and HCV NAT

    C. C. Muse, C. A. Hostetler, R. A. Squires, J. P. Orlowski

    LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK

    *Purpose: A previous review from one U.S. organ procurement organization (OPO) concluded positive HCV test results yielded high rates of authorized/not recovered donors (ANR), low…
  • 2020 American Transplant Congress

    Hepatitis C Antibody Seroconversion after Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients

    U. A. Agbim1, O. Cseprekal2, M. Yazawa1, M. Talwar1, V. Balaraman1, A. Bhalla1, P. S. Podila3, B. Maliakkal1, S. Nair1, J. D. Eason1, M. Z. Molnar1

    1James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, 2Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, 3Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN

    *Purpose: We aimed to assess factors associated with hepatitis C virus (HCV) seroconversion among HCV seronegative kidney transplant candidates receiving HCV infected donor kidneys.*Methods: This…
  • 2020 American Transplant Congress

    Racial Differences in Acceptance of Public Health Service (PHS) Increased Risk Kidneys and Hepatitis C (HCV) Nat Positive Kidneys

    K. Atiemo, S. Giusti, A. Paramesh, M. Killackey, H. Jeon

    Tulane University, New Orleans, LA

    *Purpose: PHS increased risk kidneys and HCV NAT positive kidneys represent a significant proportion of the donor pool however, acceptance demands explicit patient consent that…
  • 2020 American Transplant Congress

    Socio-Demographic Disparities in Access to Organs from HCV-Viremic Donors among HCV-Negative Patients

    T. Nguyen1, W. Williams2, M. Sise2, P. Reese3, D. Goldberg1

    1Medicine, University of Miami, Miami, FL, 2Massachusetts General Hospital, Boston, MA, 3University of Pennsylvania, Philadelphia, PA

    *Purpose: The success of pilot trials of transplanting organs from hepatitis C virus (HCV) viremic donors into HCV-negative recipients (HCV D+/R-) has led to an…
  • 2020 American Transplant Congress

    Contract a Virus to Save a Life: A Comparison of Short Term Outcomes between Adult Hepatitis C Negative Kidney Transplant Recipients Receiving a Hepatitis C NAT Positive versus Hepatitis C Negative Deceased Donor Kidney

    H. Schaefer1, B. Concepcion1, A. Sudhakar2, S. Rega1, I. Feurer1, S. Shawar1, B. Dubrey1, D. Shaffer1, R. Forbes1

    1Vanderbilt University, Nashville, TN, 2Drexel University, Philadelphia, PA

    *Purpose: The United States opioid use epidemic over the past decade has coincided with an increase in hepatitis C positive (HCV+) kidney donors. Our aim…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 28
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences